Skip to main content
Erschienen in: Reactions Weekly 1/2020

01.08.2020 | Case report

Antihyperglycaemics/prednisolone

Remitting seronegative symmetrical synovitis with pitting oedema syndrome and worsening of diabetes mellitus: 7 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Horai Y, et al. Clinical analysis of pre-existing diabetes mellitus and dipeptidyl peptidase-4 inhibitors in patients with remitting seronegative symmetrical synovitis and pitting edema syndrome. Modern rheumatology / the Japan Rheumatism Association 30: 703-707, No. 4, 3 Jul 2020. Available from: URL: http://doi.org/10.1080/14397595.2019.1666463 Horai Y, et al. Clinical analysis of pre-existing diabetes mellitus and dipeptidyl peptidase-4 inhibitors in patients with remitting seronegative symmetrical synovitis and pitting edema syndrome. Modern rheumatology / the Japan Rheumatism Association 30: 703-707, No. 4, 3 Jul 2020. Available from: URL: http://​doi.​org/​10.​1080/​14397595.​2019.​1666463
Metadaten
Titel
Antihyperglycaemics/prednisolone
Remitting seronegative symmetrical synovitis with pitting oedema syndrome and worsening of diabetes mellitus: 7 case reports
Publikationsdatum
01.08.2020
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-81363-6

Weitere Artikel der Ausgabe 1/2020

Reactions Weekly 1/2020 Zur Ausgabe

Case report

Antineoplastics

Case report

Multiple drugs

Case report

Levamisole abuse